Legal Representation
Attorney
John W. McGlynn
USPTO Deadlines
Next Deadline
80 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
October 24, 2025
Extension Available
Until October 24, 2024
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 5, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 4, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 4, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 7, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 7, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 7, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 7, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 25, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 15, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Aug 15, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Aug 15, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Aug 15, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jul 12, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| May 27, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 24, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 24, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 29, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 29, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 9, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 24, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 13, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 13, 2023 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Apr 13, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 10, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 28, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 24, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 22, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 22, 2022 | TRPT | S | REQUEST FOR TRANSFORMATION PROCESSED - TOTAL | Loading... |
Detailed Classifications
Class 001
Biological preparations for use in industry and science, namely, proteins and protein preparations made from human blood, blood plasma or blood serum, in particular human albumin, coagulation factors and immunoglobulins; recombinant proteins for industrial and scientific use; plasma fractions in the nature of biological preparations for industrial and scientific use; excipients for the stabilization of medicines, in particular human albumin for industrial and scientific purposes
Class 005
Pharmaceutical preparations for treating infectious diseases and diseases of the immune system, namely, proteins and protein preparations made from human blood, blood plasma or blood serum; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, human albumin, coagulation factors and coagulation inhibitors, in particular factor VIII, factor IX, factor X, fibrinogen; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, recombinant proteins, in particular coagulation factors and monoclonal antibodies; pharmaceutical preparations for haematology, immunology, neurology, intensive medicine, transplantation medicine, oncology for the prevention and treatment of immune system-related diseases and disorders, neurological diseases and disorders, cancer and infections; pharmaceutical preparations for preventing and treating viral diseases, for treating diseases of the immune system, for treating autoimmune diseases and oncological diseases; immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying and toxin-neutralizing medicines
Additional Information
Pseudo Mark
BIO TEST
Classification
International Classes
001
005